Ionis reaffirms FY 2026 financial guidance unchanged from April 29 release

IONIS PHARMACEUTICALS INC

Reaffirmed FY 2026 financial guidance on July 9, 2026.
Guidance unchanged from that provided on April 29, 2026 in Q1 earnings release.
No specific financial figures disclosed in this filing; refer to prior release.

item 7.01 item 9.01

IONIS PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001140361-26-028154

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.